MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 296 filers reported holding MEDICINES CO in Q4 2019. The put-call ratio across all filers is 0.95 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $730,000 | +37.0% | 14,606 | 0.0% | 0.03% | +35.0% |
Q2 2019 | $533,000 | +30.6% | 14,606 | 0.0% | 0.02% | +17.6% |
Q1 2019 | $408,000 | +45.7% | 14,606 | 0.0% | 0.02% | +30.8% |
Q4 2018 | $280,000 | -23.9% | 14,606 | +18.7% | 0.01% | 0.0% |
Q3 2018 | $368,000 | +7.9% | 12,306 | +32.2% | 0.01% | 0.0% |
Q2 2018 | $341,000 | +11.1% | 9,306 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $307,000 | +20.9% | 9,306 | 0.0% | 0.01% | +18.2% |
Q4 2017 | $254,000 | -14.5% | 9,306 | +16.2% | 0.01% | -21.4% |
Q3 2017 | $297,000 | +12.5% | 8,006 | +15.0% | 0.01% | +7.7% |
Q2 2017 | $264,000 | +34.7% | 6,960 | +74.0% | 0.01% | +18.2% |
Q1 2017 | $196,000 | +64.7% | 4,000 | +14.3% | 0.01% | +57.1% |
Q4 2016 | $119,000 | -9.8% | 3,500 | 0.0% | 0.01% | -22.2% |
Q3 2016 | $132,000 | -92.3% | 3,500 | -81.5% | 0.01% | -66.7% |
Q2 2016 | $1,716,000 | +295.4% | 18,913 | +38.6% | 0.03% | +350.0% |
Q1 2016 | $434,000 | -17.0% | 13,650 | -2.5% | 0.01% | -25.0% |
Q4 2015 | $523,000 | +281.8% | 14,000 | +288.9% | 0.01% | +300.0% |
Q3 2015 | $137,000 | – | 3,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,778,742 | $105,616,000 | 23.17% |
Sarissa Capital Management LP | 3,636,000 | $101,626,000 | 15.30% |
BRIDGER MANAGEMENT, LLC | 2,841,761 | $79,427,000 | 6.29% |
HighVista Strategies LLC | 234,340 | $6,550,000 | 5.34% |
Slate Path Capital LP | 2,170,000 | $60,652,000 | 4.91% |
Camber Capital Management LP | 2,471,523 | $69,079,000 | 3.44% |
Antipodean Advisors LLC | 170,000 | $4,752,000 | 3.38% |
Parian Global Management LP | 152,400 | $4,260,000 | 2.96% |
DLD Asset Management, LP | 2,334,800 | $65,258,000 | 2.40% |
Boxer Capital, LLC | 600,000 | $16,770,000 | 1.94% |